INTRODUCTION
Epstein-Barr virus (EBV) is a well-recognized carcinogen that has been implicated in the etiology of several malignancies, including nasopharyngeal carcinoma [1] . The viral tropism of EBV is toward the B lymphocyte, but in very rare cases it can infect ectopic T and/or natural killer (NK) cells, leading to extranodal NK/T-cell lymphoma. Syndrome of inappropriate antidiuretic hormone secretion (SIADH) is a common cause of hyponatremia [2] , but the symptoms of SIADH are nonspecific, which make it hard to detect and treat promptly. Untreated acute hyponatremia can cause substantial morbidity and mortality [3] . Many cancers can lead to SIADH [4] , including lymphoma. According to the 2016 revision of the World Health Organization classification of lymphoid neoplasms [5] , lymphomas are classified as either Hodgkin or non-Hodgkin lymphomas, and NK-cell lymphomas are in the latter class. Although non-Hodgkin lymphoma with concomitant SIADH has been reported internationally, NK/T-cell lymphoma with concomitant SIADH has not been reported in PubMed. Herein, we present a case of NK/T-cell lymphoma in a 64-year-old woman with EBV infection accompanied
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by SIADH, and suggest that monitoring serum ions, especially serum sodium, is vital in patients with NK/ T-cell lymphoma.
CASE REPORT
A 64-year-old woman was admitted with a chief complaint of intermittent fever for 2 mo. Two months previously, the patient had a sinus infection resulting from a cold, accompanied by intermittent fevers in the afternoon, with body temperature reaching as high as 38.9 ℃. The patient had a history of nasopharyngeal carcinoma of over 30 years, which was controlled with chemotherapy; there was no recurrence to this point. One year prior, she had traveled to Europe, where she ate local food including sausage and fish.
Physical examination after admission indicated a body temperature of 37.1 ℃, heart rate of 80 bpm, respiratory rate of 18 breaths per minute, and blood pressure of 14.7/9.3 kPa. A 2.5 cm × 1 cm swollen, hard, unfixed, and painless lymph node was palpated below the left jaw. No blood congestion was found in the throat area. The left abdomen was soft with tender. No other obvious abnormalities were observed.
Laboratory tests indicated the following biochemical results: serum sodium, 137.6 mmol/L; white blood cell (WBC) count, 2.4 × 10 An imaging examination was performed on admission. Computed tomography of the lungs indicated that the bilateral axillary and mediastinal lymph nodes were slightly enlarged; enhanced computed tomography of the whole abdomen indicated swollen lymph nodes in the hepatic portal region and retroperitoneum, which did not rule out lymphoma; and bilateral ultrasound of the submandibular glands indicated several visible bilateral swollen lymph nodes. To determine the characteristics of the lymph nodes, whether lymphoma was present, and the margins of the lesion, we performed positron emission tomographycomputed tomography, bone marrow biopsy, and left submandibular lymph node biopsy. Positron emission tomography-computed tomography indicated multiple swollen lymph nodes throughout the body accompanied by increased fluorodeoxyglucose metabolism, consistent with lymphoma ( Figure 1 ). Bone marrow biopsy and immunotyping showed a myelogram with hyperplastic activity and a small number of abnormal lymphocytes, accounting for 4.80% of the visible cells other than NK lymphocytes. Biopsy of the left submandibular lymph nodes confirmed NK/T-cell lymphoma, and in situ hybridization showed multiple cells with strongly positive signal for EBV-encoded small RNA (Figure 2) .
At day 10 after admission, the patient developed The fluid intake of the patient was immediately restricted, and three times daily, two salt capsules and 10 mL of concentrated sodium chloride were administered orally. After 2 d, the patient's blood Na + level gradually increased to 126.5 mmol/L (8.6 mmol/L per day). Her mental state returned to normal, and the endocrinology department was consulted. Based on the patient's decreased plasma osmolality, urine osmolality greater than plasma osmolality, lack of skin swelling, normal blood pressure, normal renal function, no adrenal function detected on serology, and no abnormalities in imaging examination of the adrenal glands, as well as the effect of treatment, the likelihood of SIADH in the patient was high. The supplemental infusion of intravenous concentrated sodium chloride solution was discontinued, and renal sodium secretion was assayed. The hematology department was also consulted, and the patient was administered with epirubicin, vinorelbine sulfate, flumethasone, cyclophosphamide, and asparaginase chemotherapy, along with supportive treatment. We believed that the patient might be involved in stage 4B NK/T-cell lymphoma with concomitant SIADH, although with slightly lower renal sodium levels (20 mmol/L). On day 30 after admission, the patient's white blood cell (WBC) count gradually decreased to 0.1 × 10 9 /L, and the neutrophil count rapidly decreased to 0/L. The immune function of the patient declined, there were severe symptoms of infection, and respiratory function further deteriorated. On day 31 after admission, the WBC count gradually decreased to 0, various vital signs declined, and the patient died after failed resuscitation.
DISCUSSION
SIADH has a hidden onset and is a syndrome caused by excessive antidiuretic hormone (ADH) secretion by the posterior pituitary [6] . It has a high mortality rate [3] . SIADH has many causes, and many cancers can lead to SIADH. It has been reported that lymphoma cells secrete ADH, and this prolonged ADH production results in SIADH [7] [8] [9] . SIADH secondary to lymphoma is relatively rare, and SIADH secondary to NK/T-cell lymphoma has not yet been reported.
The symptoms of SIADH are nonspecific, and are primarily based on diagnostic standards published by Bartter et al [10] in 1967: (1) decreased plasma osmolality; (2) urine osmolality greater than plasma osmolality; (3) increased renal sodium secretion; (4) no skin swelling and normal blood pressure; and (5) normal renal and adrenal function. Recent studies showed that a fractional excretion of uric acid > 12% has a high sensitivity and specificity for diagnosing SIADH [11] and can serve as a new basis for confirming an SIADH diagnosis. The first-line treatment for SIADH is restriction of fluid intake. If urine osmolality is higher than 500 mOsm/kg H2O and fluid restriction is ineffective, demethylchlortetracycline, urea, tolvaptan, and other drugs are instead used for treatment [12] [13] [14] . Intravenous infusion of 20-40 mg furosemide is used to manage volume overload, and 3% hypertonic saline solution by mouth or continuous intravenous infusion can be used as necessary for correcting hyponatremia [10, 15] . During sodium solution infusion, the focus should be on changes in blood sodium rather than the rate of sodium solution infusion. In the first 24-48 h, changes in blood sodium should be closely monitored, and treatment should be adjusted accordingly to rapidly correct blood sodium to within the safe range; otherwise, correction to normal ranges will not be achieved.
Studies have shown that drugs and malignant tumors are the most common causes of SIADH [16] , and the prognosis for SIADH secondary to malignant tumors is poorer than that caused by drugs [4] . To reduce the development of SIADH, regular examinations of blood sodium should be performed when malignant tumors are discovered as well as when beginning to administer drugs that are known to cause SIADH; this can help facilitate the immediate discovery of decreased blood sodium and thus immediately manage symptoms and improve prognosis.
According to the 2016 revision of the World Health Organization classification of lymphoid neoplasms [5] , lymphomas are classified as either Hodgkin or nonHodgkin lymphomas. Non-Hodgkin lymphomas are classified as either mature B cell lymphomas or mature T-cell lymphomas, and NK-cell lymphomas are the latter. Currently, 34 cases of non-Hodgkin lymphoma with concomitant SIADH have been reported internationally [7, 8, [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] (Table 1) .
The male/female ratio of these 34 cases was 19:15, mean age was 69 years (range 23-84 years), and patients aged between 60 and 90 years accounted for 85% (29/34) of the patients. The clinical manifestations of SIADH in these cases were nonspecific, and large B-cell lymphoma made up 47% (16/34) of all the pathological types. Based on the known treatment data, the main treatment was fluid restriction, which was administered to 80% (16/20) . The ratio of outcomes died/cured/unknown was 17:10:7, and the mortality rate of known outcomes was 63% (17/27). The clinical characteristics of known cases may be useful for clinicians to remain aware for these characteristics in patients who may be at risk for SIADH.
The pathogenesis of SIADH secondary to lymphoma 
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Demirkan et al [19] 2001 [7, 10, 30] . In our case, because of the death of the patient, whether hyponatremia was recurrent could not be determined, and abnormal secretion of ADH by lymphocytes could not be ruled out. Central nervous system injury secondary to nonHodgkin lymphomas may also play an important role in the pathogenesis of SIADH [10] . Hyponatremia can also lead to nervous system symptoms [10] , but the likelihood of central nervous system injury in our patient was low. The use of chemotherapy drugs such as vinca alkaloids and cyclophosphamide can also induce SIADH [35] . However, before SIADH was discovered in our patient, no chemotherapy drugs had been administered, so this did not apply in our case.
Hypercytokinemia is another important factor in the development of SIADH secondary to lymphoma. Studies have shown that the levels of epidermal growth factor (EGF), granulocyte colony-stimulating factor (G-CSF), interleukin (IL)-5, IL-6, IL-12, IP-10, sIL-2Rα, membrane immunoglobulin (MIG), IL-1RA, and other cytokines are significantly elevated in T-cell lymphomas [36, 37] . In extranodal nasal type NK/T-cell lymphomas, sIL-2Rα, IL-6, and IL-10 are significantly elevated [38] . Increased IL-2, sIL-2R, IL-6, IL-1β, and tumor necrosis factor (TNF)-α can lead to abnormal secretion of ADH [39] . Watabe et al [23] found that patients with high levels of the cytokine IL-6 are more likely to develop SIADH. We did not examine the levels of cytokines in our patient; however, it cannot be ruled out that SIADH in our patient was associated with abnormal secretion of ADH by lymphocytes or that the lymphoma regulated ADH secretion through cytokines. EBV is a member of the human herpesvirus family and its genome consists of a single double-stranded DNA molecule. It has a high infection rate, with potentially 90% or more of all individuals infected worldwide [40, 41] . Humans are the only host for EBV and they become lifelong carriers of the virus after infection. Most hosts can live with EBV for a long period without any serious effects, but in some individuals, EBV is closely associated with the development of malignant tumors [42] , including nasopharyngeal carcinoma and lymphomas. The viral tropism of EBV is toward B lymphocytes, but in very rare cases, it can infect ectopic T and/or NK cells, leading to chronic active EBV infection, extranodal NK/T-cell lymphoma, or invasive NK cell leukemia [43] . EBV can be divided into three latency programs. Latency Ⅱ shows expression of EBV nuclear antigen 1 (EBNA1) and latent membrane proteins (LMPs), and is closely associated with the development of peripheral NK/T-cell lymphoma and nasopharyngeal carcinoma in elderly patients [42, [44] [45] [46] . Our patient had been diagnosed with both nasopharyngeal carcinoma and NK/T-cell lymphoma, and the possibility of long-term latent EBV infection cannot be ruled out.
According to the 2016 revision of the World Health Organization classification of lymphoid neoplasms, NK/T-cell lymphoma is categorized into mature T-cell lymphoma and extranodal nasal type NK/T-cell lymphoma. The latter type is a relatively rare lymphoma characterized by high invasiveness, poor prognosis, and high likelihood of recurrence. According to a 2010 report, extranodal nasal type NK/T-cell lymphoma accounts for 6.9% of non-Hodgkin lymphomas and 28.2% of T-cell and NK cell lymphomas in China [47, 48] . Eighty to ninety percent of patients with nasal type NK/ T-cell lymphoma report symptoms of nasal congestion, sinus infection, ulceration, and epistaxis [48] . Traditional treatments include chemotherapy, radiotherapy, and multimodal therapy, but even in patients with stage Ⅰ or Ⅱ disease, the 3-year survival rate is only 40%-50% [49] [50] [51] . Most published studies related to the efficacy of chemotherapy in extranodal NK/T-cell lymphoma have shown that the recurrence rate is as high as 50% [52] . Our patient was diagnosed with nasopharyngeal carcinoma 30 years earlier without recurrence following control with chemotherapy, but specific pathological examination results were not obtained. In addition, paraffin sections from over 30 years ago cannot be re-stained. Given the limitations of Akhtar et al [17] Liu QB et al . NK/T-cell lymphoma with SIADH previous pathological examinations, the possibility that the patient developed extranodal nasal type NK/T-cell lymphoma cannot be ruled out. However, based on its biological characteristics, namely, a high recurrence rate, high invasiveness, and poor prognosis, the likelihood that our patient developed extranodal nasal type NK/T-cell lymphoma 30 years ago is small.
In summary, NK/T-cell lymphoma with concomitant SIADH is relatively rare. Blood sodium must be closely monitored in lymphoma patients as an indicator of the development of SIADH, and immediate treatment by restricting fluid intake and replenishing sodium should be administered based on blood sodium levels. At the same time, actively searching for the cause of the disease and planning adjunctive therapy with drugs as needed will prevent critical patients from developing hyponatremia and hypo-osmolality, thereby improving their prognosis.
Article Highlights

Case characteristics
A 64-year-old woman was admitted with intermittent fever for 2 mo.
Clinical diagnosis
Stage 4B natural killer (NK)/T-cell lymphoma with concomitant syndrome of inappropriate antidiuretic hormone secretion (SIADH).
Differential diagnosis
Infection, typhia, brucellosis, etc.
Laboratory diagnosis
As determined by blood and urine sampling examination, serum Na + was 109.3 mmol/L, urea was 2.99 mmol/L, serum creatinine was 47.8 μmol/L, plasma osmolality was 235.39 mOsm/kg, and urine osmolality was 494 mOsm/kg.
Imaging diagnosis
Positron emission tomography-computed tomography indicated multiple swollen lymph nodes throughout the body accompanied by increased fluorodeoxyglucose metabolism, consistent with lymphoma.
Pathological diagnosis
Biopsy of the left submandibular lymph nodes confirmed NK/T-cell lymphoma.
Treatment
Chemotherapy, fluid restriction, and administration of sodium chloride.
Related reports
This is the first known report of NK/T-cell lymphoma with concomitant SIADH in PubMed.
Term explanation
Lymphoma is one of the causes of SIADH; however, NK/T-cell lymphoma with concomitant SIADH has not been reported.
Experiences and lessons
This case report emphasizes the importance of monitoring serum ions and etiological treatment in patients with NK/T-cell lymphoma.
